Elicio Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Elicio Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q1 2024.
  • Elicio Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $82K, a 25.5% decline year-over-year.
  • Elicio Therapeutics, Inc. annual Depreciation for 2023 was $382K, a 2.05% decline from 2022.
  • Elicio Therapeutics, Inc. annual Depreciation for 2022 was $390K, a 329% increase from 2021.
  • Elicio Therapeutics, Inc. annual Depreciation for 2021 was $91K, a 7.14% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $82K -$28K -25.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q3 2023 $0 -$100K -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q1 2023 $110K +$78K +244% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $100K +$77K +335% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q1 2022 $117K $32K +$26K +433% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $91K $39K +$62K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 $29K $23K -$24K -51.1% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $53K $23K -$24K -51.1% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $77K $6K -$21K -77.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $98K -$23K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $47K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $47K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $27K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.